GainTherapeutics

Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. Gain was originally established in 2017 with the support of its founders and institutional investors such as TiVenture, 3B Future Health Fund (previously known as Helsinn Investment Fund) and VitaTech.